Perioperative Tislelizumab Plus Intensity Modulated Radiotherapy in Resectable Hepatocellular Carcinoma with Macrovascular Invasion: a Phase II Trial
Nature Communications(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Nature Communications(2024)